false
2025
Q2
--12-31
0002038439
0002038439
2024-10-01
2025-03-31
0002038439
us-gaap:CommonStockMember
2024-10-01
2025-03-31
0002038439
VWAV:WarrantsMember
2024-10-01
2025-03-31
0002038439
2025-10-03
0002038439
2025-03-31
0002038439
2024-09-30
0002038439
2025-01-01
2025-03-31
0002038439
us-gaap:CommonStockMember
2024-09-30
0002038439
us-gaap:AdditionalPaidInCapitalMember
2024-09-30
0002038439
us-gaap:RetainedEarningsMember
2024-09-30
0002038439
us-gaap:CommonStockMember
2024-12-31
0002038439
us-gaap:AdditionalPaidInCapitalMember
2024-12-31
0002038439
us-gaap:RetainedEarningsMember
2024-12-31
0002038439
2024-12-31
0002038439
us-gaap:CommonStockMember
2024-10-01
2024-12-31
0002038439
us-gaap:AdditionalPaidInCapitalMember
2024-10-01
2024-12-31
0002038439
us-gaap:RetainedEarningsMember
2024-10-01
2024-12-31
0002038439
2024-10-01
2024-12-31
0002038439
us-gaap:CommonStockMember
2025-01-01
2025-03-31
0002038439
us-gaap:AdditionalPaidInCapitalMember
2025-01-01
2025-03-31
0002038439
us-gaap:RetainedEarningsMember
2025-01-01
2025-03-31
0002038439
us-gaap:CommonStockMember
2025-03-31
0002038439
us-gaap:AdditionalPaidInCapitalMember
2025-03-31
0002038439
us-gaap:RetainedEarningsMember
2025-03-31
0002038439
us-gaap:SubsequentEventMember
2025-04-09
0002038439
us-gaap:SubsequentEventMember
2025-04-08
2025-04-09
0002038439
us-gaap:SubsequentEventMember
2025-09-09
0002038439
2025-03-30
0002038439
us-gaap:SubsequentEventMember
2025-09-08
0002038439
us-gaap:SubsequentEventMember
VWAV:SecondPrePaidAdvanceMember
2025-09-11
0002038439
us-gaap:SubsequentEventMember
VWAV:AdditionalAdvanceMember
2025-09-11
0002038439
us-gaap:SubsequentEventMember
2026-09-11
0002038439
us-gaap:SubsequentEventMember
2026-09-10
2026-09-11
0002038439
us-gaap:SubsequentEventMember
2025-09-11
0002038439
us-gaap:SubsequentEventMember
2025-09-10
2025-09-24
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
xbrli:pure
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM 10-Q
☒ QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period
ended
March 31, 2025
☐ TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period
from to
VisionWave Holdings, Inc. |
(Exact Name of Registrant as Specified in its Charter) |
Delaware |
|
001-72741 |
|
99-5002777 |
(State or other jurisdiction of
incorporation) |
|
(Commission File Number) |
|
(I.R.S. Employer
Identification No.) |
300 Delaware Ave., Suite 210 # 301
Wilmington, DE. |
19801 |
(Address of Principal Executive Offices) |
(Zip Code) |
Registrant’s telephone number, including area code: (302) 305-4790 |
|
N/A |
(Former name or former address, if changed since last report) |
Securities registered pursuant
to Section 12(b) of the Securities Exchange Act of 1934:
Title of each class |
|
Trading
Symbol(s) |
|
Name of each exchange on which registered |
Common Stock |
|
VWAV |
|
The Nasdaq Stock Market LLC |
Warrants |
|
VWAVW |
|
The Nasdaq Stock Market LLC |
Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities
Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports),
and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405
of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant
was required to submit such files). Yes ☒No ☐
Indicate by check mark whether
the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging
growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting
company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer |
☐ |
Accelerated filer |
☐ |
Non-accelerated filer |
☒ |
Smaller reporting company |
☒ |
Emerging growth company |
☒ |
|
|
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐
No ☒
As of October 3, 14,521,093
shares of common stock, par value $0.01 per share, were issued and outstanding.
Explanatory Note:
On July 14, 2025, VisionWave Technologies Inc.
(“VW Tech”) completed its business combination with Bannix Acquisition Corp. (“Bannix”) pursuant to a double-dummy
merger structure. As part of the transaction, both VW Tech and Bannix became wholly owned subsidiaries of a newly formed parent company,
VisionWave Holdings Inc. (“the Company”). This Quarterly Report on Form 10-Q is filed by VisionWave Holdings Inc. under its
current name and CIK. However, because the business combination closed after the period covered by this report (March 31, 2025), the financial
statements and related disclosures presented herein reflect the historical operations of Bannix Acquisition Corp. only. The operations
of VW Tech will be included in the Company’s consolidated financial statements beginning with the Form 10-Q for the quarter ending
March 31, 2025.
VISIONWAVE HOLDINGS, INC.
FORM 10-Q FOR THE QUARTER
ENDED MARCH 31, 2025
TABLE OF CONTENTS
|
Page |
Part
I. Financial Information |
3 |
Item
1. Financial Statements |
|
Condensed
Consolidated Balance Sheets as of March 31, 2025 (unaudited) and September 30, 2024 |
3 |
Unaudited
Condensed Consolidated Statements of Operations for the three and six months ended March 31, 2025 |
4 |
Unaudited
Condensed Consolidated Statements of Changes in Stockholders’ Deficit for the three and six months ended March 31, 2025 |
5 |
Unaudited
Condensed Consolidated Statements of Cash Flows for the six months ended March 31, 2025 |
6 |
Notes
to Unaudited Condensed Consolidated Financial Statements |
7 |
Item
2. Management’s Discussion and Analysis of Financial Condition and Results of Operations |
15 |
Item
3. Quantitative and Qualitative Disclosures Regarding Market Risk |
20 |
Item
4. Controls and Procedures |
20 |
Part
II. Other Information |
22 |
Item
1. Legal Proceedings |
22 |
Item
1A. Risk Factors |
22 |
Item
2. Unregistered Sales of Equity Securities and Use of Proceeds from Registered Securities |
23 |
Item
3. Defaults Upon Senior Securities |
23 |
Item
4. Mine Safety Disclosures |
23 |
Item
5. Other Information |
23 |
Item
6. Exhibits |
24 |
Part
III. Signatures |
26 |
PART I – FINANCIAL INFORMATION
VISIONWAVE HOLDINGS,
INC.
CONDENSED CONSOLIDATED
BALANCE SHEETS
| |
| | | |
| | |
| |
March 31, 2025 | |
September 30, 2024 |
| |
(Unaudited) | |
|
Assets | |
| | | |
| | |
Total Current Assets | |
$ | — | | |
$ | — | |
Total Assets | |
$ | — | | |
$ | — | |
| |
| | | |
| | |
Liabilities and Stockholder’s Deficit | |
| | | |
| | |
Current liabilities: | |
| | | |
| | |
Accounts payable | |
$ | 18,753 | | |
$ | — | |
Due to related parties | |
| 47,556 | | |
| 3,056 | |
Total Current Liabilities | |
| 66,309 | | |
| 3,056 | |
Total Liabilities | |
| 66,309 | | |
| 3,056 | |
| |
| | | |
| | |
Stockholder’s Deficit | |
| | | |
| | |
Common stock, par value $0.01; authorized 1,000 shares; issued and outstanding 1 share | |
| — | | |
| — | |
Additional paid-in capital | |
| — | | |
| — | |
Accumulated deficit | |
| (66,309 | ) | |
| (3,056 | ) |
Total Stockholder’s Deficit | |
| (66,309 | ) | |
| (3,056 | ) |
TOTAL LIABILITIES AND STOCKHOLDER’S DEFICIT | |
$ | — | | |
$ | — | |
The accompanying notes are
an integral part of these unaudited condensed consolidated financial statements.
VISIONWAVE HOLDINGS, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
| |
| | | |
| | |
| |
For the Three Months | |
For the Six Months |
| |
Ended March 31, | |
Ended March 31, |
| |
2025 | |
2025 |
Operating costs | |
$ | 60,253 | | |
$ | 63,253 | |
Loss from operations | |
| (60,253 | ) | |
| (63,253 | ) |
| |
| | | |
| | |
Net loss | |
$ | (60,253 | ) | |
$ | (63,253 | ) |
| |
| | | |
| | |
Weighted average number of shares of common stock outstanding, basic and diluted | |
| 1 | | |
| 1 | |
Basic and diluted net loss per share of common stock | |
$ | (60,253 | ) | |
$ | (63,253 | ) |
The accompanying notes are
an integral part of these unaudited condensed consolidated financial statements.
VISIONWAVE HOLDINGS, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDER’S DEFICIT
FOR THE THREE AND SIX MONTHS ENDED MARCH 31, 2025
| |
| | | |
| | | |
| | | |
| | | |
| | |
| |
Common stock | |
| |
| |
|
| |
Share | |
Amount | |
Additional Paid-in Capital | |
Accumulated Deficit | |
Total Stockholder’s Deficit |
Balance as of September 30, 2024 | |
| 1 | | |
$ | — | | |
$ | — | | |
$ | (3,056 | ) | |
$ | (3,056 | ) |
Net loss | |
| — | | |
| — | | |
| — | | |
| (3,000 | ) | |
| (3,000 | ) |
Balance as of December 31, 2024 | |
| 1 | | |
$ | — | | |
$ | — | | |
$ | (6,056 | ) | |
$ | (6,056 | ) |
Net loss | |
| — | | |
| — | | |
| — | | |
| (60,253 | ) | |
| (60,253 | ) |
Balance as of March 31, 2025 | |
| 1 | | |
$ | — | | |
$ | — | | |
$ | (66,309 | ) | |
$ | (66,309 | ) |
The accompanying notes are
an integral part of these unaudited condensed consolidated financial statements.
VISIONWAVE HOLDINGS, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
| |
| | |
| |
For the Six Months Ended March 31, 2025 |
Cash flows from Operating Activities: | |
| | |
Net loss | |
$ | (63,253 | ) |
Adjustments to reconcile net loss to net cash used in operating activities: | |
| | |
Changes in current assets and current liabilities: | |
| | |
Accounts payable | |
| 18,753 | |
Net cash used in operating activities | |
| (44,500 | ) |
| |
| | |
Cash flows from Financing Activities: | |
| | |
Proceeds from related parties | |
| 44,500 | |
Net cash provided by financing activities | |
| 44,500 | |
| |
| | |
Net change in cash | |
| — | |
Cash, beginning of the period | |
| — | |
Cash, end of the period | |
$ | — | |
The accompanying notes are
an integral part of these unaudited condensed consolidated financial statements.
VISIONWAVE HOLDINGS, INC.
NOTES TO UNAUDITED CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2025
Note 1—Organization
and Business Operations
Organization and General
Description of Business
VisionWave Holdings, Inc. (the “Company”)
was incorporated in Delaware on September 3, 2024, and the Company’s registered office is at 108 W. 13th Street, Suite
100, City of Wilmington, Delaware. The Company was formed as a wholly- owned subsidiary of Bannix Acquisition Corp. (“Bannix”).
The Company has selected September 30 as its fiscal
year end.
BNIX Merger Sub, Inc. (“Parent Merger
Sub”) was incorporated in Delaware on September 3, 2024, and the Company’s registered office is at 108 W. 13th
Street, Suite 100, City of Wilmington, Delaware. The Company was formed as a wholly- owned subsidiary of the Company.
BNIX VW Merger Sub, Inc. (“Company
Merger Sub”) was incorporated in Nevada on September 4, 2024, and the Company’s registered office is at 701 S. Carson Street,
Suite 200, Carson City, Nevada 89701. The Company was formed as a wholly-owned subsidiary of the Company.
Proposed Business Combination
On September 6, 2024, Bannix entered into
a Merger Agreement and Plan of Reorganization (the “Merger Agreement”), by and among Bannix, the Company, BNIX Merger Sub,
Inc., a Delaware corporation and a direct, wholly owned subsidiary of the Company (“Parent Merger Sub”), BNIX VW Merger Sub,
Inc., a Nevada corporation and direct, wholly owned subsidiary of the Company (“Company Merger Sub”), and VisionWave Technologies,
Inc., a Nevada corporation (“Target”). The Merger Agreement and the transactions contemplated thereby were approved by the
boards of directors of each of Bannix, the Company, Parent Merger Sub, Company Merger Sub, and Target.
The Business Combination is expected to
close before June 30, 2025, subject to customary closing conditions, including the satisfaction of the minimum available cash condition,
the receipt of certain governmental approvals and the required approval by the stockholders of Bannix and Target.
Liquidity, Capital Resources and Going
Concern
The Company was formed for the purpose
of consummating a business combination and is not anticipated to exist upon consummation of the Merger Agreement.
The parent company, Bannix, is within 12
months of its mandatory liquidation date as of June 30, 2025. In connection with the Company’s assessment of going concern considerations,
the Company had a temporarily extended deadline date beyond the June 14, 2025 Deadline Date to consummate a Business Combination. The
Company closed on its proposed Business Combination on July 14, 2025 alleviating the mandatory liquidation requirement.
In connection with preparing
the financial statements for the Three and Six months ended March 31, 2025, management evaluated whether there were conditions and events,
considered in the aggregate, that raised substantial doubt about the Company’s ability to continue as a going concern within one
year from the date that the consolidated financial statements are issued.
As of March 31, 2025, the Company had no
cash, a working capital deficit of $66,309 and no sources of funding other than funds that may be obtained from related parties.
Ordinarily, conditions or events that raise
substantial doubt about an entity’s ability to continue as a going concern relate to the entity’s ability to meet its obligations
as they become due.
The Company evaluated its ability to meet
its obligations as they become due within one year from the date that the financial statements are issued by considering the following:
On April 8, 2025, with an effective date of March 31, 2025, Bannix, together
with the Company, entered into a Funding Support Agreement with Stanley Hills, LLC (“Stanley Hills”), the principal shareholder
of the VisionWave Technologies, Inc. And on October 3, 2025, the Funding Support Agreement was revised such that the Company was included
as the primary party to the Funding Support Agreement. Pursuant to the agreement, Stanley Hills irrevocably and unconditionally committed
to provide financial support to Bannix, sufficient to fund working capital needs for a period not less than twelve (12) months from the
date of release/issuance of the financial statement.
The funding may be provided by Stanley
Hills in the form of direct payments to third parties, advances or intercompany loans, or capital contributions, as mutually determined
by the parties. Unless otherwise agreed in writing, any such advances will be non-interest bearing and repayable only at such time as
determined by the applicable entity’s Board of Directors, and only to the extent such repayment would not impair the Company’s
liquidity or ability to continue as a going concern. The agreement may not be terminated by Stanley Hills prior to the twelve-month period
from the date of release of the financial statement.
Management has determined that the agreement
with Stanley Hills and closing of the business combination elevated the risk about the Company’s ability to continue as a going
concern for a reasonable period of time, which is considered to be one year from the issuance of the financial statements.
The merger closing triggered substantial,
actionable, and committed below funding access:
• Investor A is actively pushing
to draw $2 million immediately and has committed to a $50 million equity line.
• Investor B has offered the Company
$2 million in $300K tranches, and is likewise eager for us to proceed post-closing.
• Investor C is to finalize their
$18 million ELOC and a $5 million pre-paid advance.
VISIONWAVE HOLDINGS,
INC.
NOTES TO UNAUDITED CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2025
Note 2—Significant
Accounting Policies
Basis of Presentation
The accompanying unaudited condensed consolidated
financial statements of the Company are presented in U.S. dollars in conformity with accounting principles generally accepted in the United
States of America for interim financial information (“US GAAP”) and pursuant to Rule 8-03 of Regulation S-X promulgated by
the SEC. Accordingly, they do not include all of the information and footnotes required by US GAAP. In the opinion of management, the
unaudited condensed consolidated financial statements reflect all adjustments, which include only normal recurring adjustments necessary
for the fair statement of the balances and results for the period presented. Operating results for the three and
six months ended March 31, 2025 are not necessarily indicative of the results that may be expected through September 30, 2025.
Certain information and footnote disclosures
normally included in the annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. These unaudited
condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements
and notes thereto for the period from September 3, 2024 (inception) through September 30, 2024. The balance sheet as of March
31, 2025 contained herein has been derived from the audited financial statements as of September 30, 2024, but does not include
all disclosures required by U.S. GAAP.
The Company incorporated on September 3,
2024, therefore no prior year comparative amounts are available for the statement of operations, statement of stockholder’s deficit
and statement of cash flows.
Principles of Consolidation
The accompanying unaudited condensed consolidated
financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany transactions have been eliminated.
Segment Reporting
The Company complies with ASU 2023-07,
Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (ASU 2023-07), which improves reportable segment disclosure
requirements, primarily through enhanced disclosures about significant segment expenses among other disclosure requirements. The Company
adopted ASU 2023- 07 on October 1, 2024. The amendments were applied retrospectively to all prior periods presented in the financial statements
(see Note 6).
Use of Estimates
The preparation of condensed consolidated
financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated
financial statements and the reported amounts of revenues and expenses during the reporting period.
Making estimates requires management to
exercise significant judgment. It is at least reasonably possible that the estimate is the effect of a condition, situation or set of
circumstances that existed at the date of the condensed consolidated financial statements, which management considering in formulating
its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ
significantly from those estimates.
Net Loss Per Share
Basic net loss per share is computed by dividing net loss by the weighted
average number of shares of common stock outstanding during the period.
For purposes of calculating diluted loss
per common share, the denominator includes both the weighted average number of shares of common stock outstanding during the period and
the number of common stock equivalents if the inclusion of such common stock equivalents is dilutive.
VISIONWAVE HOLDINGS,
INC.
NOTES TO UNAUDITED CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2025
Recently Issued Accounting Pronouncements
In November 2023, the FASB issued ASU 2023-07,
Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (ASU 2023-07), which improves reportable segment disclosure
requirements, primarily through enhanced disclosures about significant segment expenses among other disclosure requirements. ASU 2023-07
is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15,
2024. Early adoption is permitted. The Company adopted ASU 2023-07 on October 1, 2024. The amendments will be applied retrospectively
to all prior periods presented in the financial statements. The adoption of ASU 2023-07 has not had a material impact on the Company’s
unaudited condensed consolidated financial statements and disclosures.
The Company has reviewed recently issued
accounting pronouncements and plans to adopt those that are applicable to it.
The Company does not expect the adoption
of any recently issued pronouncements to have a material impact on its results of operations or financial position.
NOTE 3 — RELATED PARTY TRANSACTIONS
On April 8, 2025, and made effective as
of March 31, 2025, the Company entered into a funding agreement with Stanley Hills, LLC (“Stanley Hills”), the principal shareholder
of VW Technologies, Inc., whereby Stanley Hills has agreed to fund the Company’s working capital needs for a period of not less
than twelve (12) months from March 31, 2025. This agreement is non-interest bearing, and repayable only at such time as determined by
the respective Company’s Board of Directors in its sole discretion, and only to the extent such repayment would not impair the Company’s
liquidity or going concern status.
The sponsor of the Bannix, Instant Fame
LLC, a Nevada limited liability company (“Instant”) and Stanley Hills have paid expenses on behalf of the Company and the
Company’s subsidiaries, and are expected to continue to pay other costs in the future.
As of March 31, 2025 and September 30, 2024, the Company owes related parties $47,556 and
$3,056, respectively. Instant or related parties are expected to pay the accrued expenses of the Company when they come due.
NOTE 4 — STOCKHOLDER’S DEFICIT
Common stock
The Company is authorized to issue 1,000
shares of common stock with a par value of $0.01 each. As of March 31, 2025 and September 30, 2024
there was 1 one share of common stock issued and outstanding. Each share of common stock entitles the holder to one vote.
NOTE 5 — COMMITMENTS
AND CONTINGENCIES
Legal Proceedings
In September 2025, a shareholder filed a
lawsuit against the Company seeking from court a declaration that it is not an affiliate of the Company. The Company is contesting the
shareholder’s position. At each reporting date, the Company evaluates whether or not a potential loss amount or a potential range
of loss is probable and reasonably estimable under the provisions of the authoritative guidance that addresses accounting for contingencies.
At this phase the Company cannot estimate the results of said litigation. The Company expenses as incurred the costs related to such legal
proceedings.
NOTE 6—SEGMENT
INFORMATION
ASC Topic 280 establishes standards for
companies to report in their financial statement information about operating segments, products, services, geographic areas, and major
customers. Operating segments are defined as components of an enterprise for which separate financial information is available that is
regularly evaluated by the Company’s chief operating decision maker, or group, in deciding how to allocate resources and assess
performance.
VISIONWAVE HOLDINGS,
INC.
NOTES TO UNAUDITED CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2025
The Company’s chief operating decision
maker (“CODM”) has been identified as the Chief Executive Officer, who reviews the consolidated operating results for the
Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined
that the Company only has one operating segment.
The CODM assesses performance for the single
segment and decides how to allocate resources based on net income or loss that also is reported on the statements of operations as net
income or loss. When evaluating the Company’s performance and making key decisions regarding resource allocation, the CODM reviews
key metrics, which include the following:
Schedule of segment assets | |
| |
|
| |
For the Three Months Ended | |
For the Six Months Ended |
| |
March 31, | |
March 31, |
| |
2025 | |
2025 |
Operating costs | |
$ | 60,253 | | |
$ | 63,253 | |
The key metrics included in segment profit
or loss reviewed by the CODM are operating costs.
Operating costs are reviewed and monitored
by the CODM to manage and forecast cash to ensure enough capital is available to complete a business combination within the combination
period. The CODM also reviews operating costs to manage, maintain and enforce all contractual agreements to ensure costs are aligned with
all agreements and budget.
NOTE 7 — SUBSEQUENT EVENTS
The Company evaluated subsequent events and transactions that occurred after
the balance sheet date up to the date the unaudited condensed consolidated financial statements are issued (October 3, 2025). The Company
did not identify any subsequent events that would have required adjustment or disclosure in these unaudited condensed consolidated financial
statements, other than below.
On April 9, 2025, the Company entered into
a non-exclusive placement agent engagement agreement (the “Engagement Agreement”) with Maxim Group LLC (“Maxim”),
pursuant to which Maxim will act as the Company’s non-exclusive placement agent in connection with a potential private placement
of up to $10 million of equity or equity-linked securities (the “Offering”). The Offering is expected to be conducted on a
“commercially reasonable efforts” basis, and there is no assurance that the Offering will be completed, or that any definitive
agreements with investors will be entered into. Under the terms of the Engagement Agreement, the Company retains full discretion to accept
or reject any investment proposals and will determine the final terms and structure of the Offering, subject to market conditions and
investor interest. Maxim will be entitled to a cash placement fee equal to seven percent (7.0%) of the gross proceeds received by the
Company from any investor introduced by Maxim and listed in exhibit to the Engagement Agreement. In addition, the Company agreed to reimburse
Maxim for up to $25,000 in out-of-pocket expenses incurred in connection with the engagement, subject to certain conditions and prior
approvals.
The Engagement Agreement also includes customary
confidentiality, indemnification, and contribution provisions, as well as a limited right of first refusal. Specifically, for a period
of nine (9) months following the final closing of the Offering, Maxim shall have the right to act as sole managing underwriter or sole
placement agent for any subsequent public or private offerings of equity, equity-linked, or debt securities of the Company, subject to
Maxim matching the material terms offered by any third party. The Company has not yet launched the Offering, and no securities have been
issued as of the date of this filing. The terms of the Offering will be subject to further negotiation, execution of definitive agreements
with investors, satisfaction of customary closing conditions, and successful completion of Maxim’s due diligence.
There can be no assurance that the Company
will consummate the Offering or receive any proceeds from it. Any securities that may be issued in connection with the Offering will be
offered and sold in reliance upon exemptions from registration under the Securities Act of 1933, as amended, and applicable state securities
laws.
On April 18, 2025, the Company filed Form
S-4/A with the SEC related to the Company’s proposed Business Combination as discussed in Note 1.
On May 5, 2025, the Securities and Exchange
Commission (“SEC”) declared the Company’s registration statement filed with the SEC on April 18, 2025 to be effective.
Board of Directors
On September 9, 2025, the
Board of Directors (the “Board”) of the Company approved Independent Director Agreements (each, an “Agreement”)
with Eric Shuss, Chuck Hansen, and Haggai Ravid, pursuant to which each will serve as an independent director of the Company.
Under the terms of each
Agreement, the independent director will receive:
|
● |
An
annual cash retainer of $36,000, payable quarterly, and $10,000 per annum for serving as the audit committee chair, $5,000 for compensation
committee chair and the governance committee chair; |
|
● |
Reimbursement
for reasonable expenses incurred in connection with Board service; and |
|
● |
An
annual equity grant under the Company’s 2024 Omnibus Equity Incentive Plan (the “Plan”) with a grant date fair
value of $60,000, consisting of restricted stock vesting in full after one year of service. |
As a result of the above,
the Company will issue 5,245 shares of common stock to Messrs Shuss, Hansen and Ravid for their service in 2025.
Further, as compensation
for his service as a director prior to the Business Combination with Bannix Acquisition Corp. (“Bannix”), the Company entered
into Compensation Agreements (each, a “Compensation Agreement”) with Mr. Shuss and two other former directors who served as
an independent director on the Board of Directors of Bannix from October 2022 until July 2025. Pursuant to the Compensation Agreement,
effective as of September 9, 2025, Mr. Shuss will receive a one-time lump sum compensation of $150,000, payable in cash, fully vested
shares of the Company’s common stock issued under the Company’s Plan, or a combination thereof, at Mr. Shuss’ election.
If shares are elected, the number of shares will be determined by dividing the elected portion by the closing price of the Company’s
common stock on the NASDAQ Stock Market immediately prior to the effective date of the Compensation Agreement. Mr. Shuss has elected to
receive 6,556 shares of common stock using a closing price of $11.44 as of September 8, 2025. The shares will be fully vested upon issuance
but subject to resale restrictions under Rule 144 of the Securities Act of 1933, as amended. Payment or issuance will occur within 10
business days after the election (or default to cash if no election is made within 10 business days).
Financing
On September 11, 2025, the
Company entered into a letter agreement (the “Letter Agreement”) with YA II PN, Ltd., a Cayman Islands exempt limited partnership
(the “Investor”), pursuant to the Standby Equity Purchase Agreement, dated as of July 25, 2025 (as may be amended, amended
and restated, extended, supplemented or otherwise modified in writing from time to time, the “SEPA”), between the Company
and the Investor.
Pursuant to the Letter Agreement,
the Investor advanced the second tranche of the Pre-Paid Advance in a principal amount of $2,000,000 (the “Second Pre-Paid Advance”)
on September 11, 2025, in connection with the issuance by the Company of a convertible promissory note in the principal amount of $2,000,000
(the “Second Note”). The Investor waived the condition precedent set forth in the SEPA relating to the effectiveness of a
registration statement for the Second Pre-Paid Advance. The purchase price for the Second Note is $1,880,000 (94% of the principal amount,
reflecting a 6% discount).
In addition, pursuant to
the Letter Agreement, the Investor agreed to fund an additional $2,000,000 in principal amount (the “Additional Advance”)
under the terms of a new convertible promissory note in the principal amount of $2,000,000 (the “New Note” and, together with
the Second Note, the “Additional Notes”) upon the effectiveness of the registration statement filed by the Company on August
29, 2025, in connection with the SEPA (the “Registration Statement”). The purchase price for the New Note will be $1,880,000
(94% of the principal amount, reflecting a 6% discount). The Company acknowledged in the Letter Agreement that it is not required to modify,
amend, or supplement the existing Registration Statement to include any shares underlying the New Note, and, other than as may be set
forth in the New Note, the Company is not obligated to file a new registration statement relating to such shares.
Terms of the Second Note
The Second Note has a maturity
date of September 11, 2026 (as may be extended at the option of the Investor). Interest accrues on the outstanding principal balance at
an annual rate of 6%, which increases to 18% upon the occurrence of an event of default (for so long as such event remains uncured). Interest
is calculated based on a 365-day year and the actual number of days elapsed.
If an Amortization Event
occurs (defined as a Floor Price Event, Exchange Cap Event, or Registration Event, as set forth in the Second Note), the Company must
make monthly cash payments beginning on the 10th trading day after the Amortization Event Date and continuing on the same day of each
successive calendar month until the entire outstanding principal amount is repaid. Each monthly payment equals the sum of (i) $750,000
of principal (or the outstanding principal if less), (ii) a 7% payment premium on such principal amount, and (iii) accrued and unpaid
interest. The obligation to make such payments ceases if the Amortization Event is cured.
The Company may, at its
option, redeem early a portion or all amounts outstanding under the Second Note by providing written notice to the Investor, provided
the VWAP of the common stock was less than the fixed conversion price on the notice date (unless otherwise agreed). The redemption amount
includes the principal being redeemed, a 5% redemption premium, and accrued interest. The Investor has 10 trading days to elect to convert
any portion of the Second Note before redemption.
The Second Note is convertible
at any time into shares of the Company’s common stock, par value $0.01 per share (the “Common Stock”), at the lower
of (i) $10.00 per share (the “Fixed Price”) or (ii) 93% of the lowest daily VWAP during the 5 consecutive trading days immediately
preceding the conversion date (the “Variable Price”), but not lower than the floor price of $1.00 per share (adjustable downwards
to 20% of the average VWAP for the five trading days prior to the earlier of the Registration Statement effectiveness or the six-month
anniversary of the SEPA date, or further reduced by the Company). The Fixed Price resets downwards on the 30-day anniversary of a merger
transaction to the average VWAP for the five trading days prior. Conversions are subject to a 4.99% beneficial ownership limitation and
the Exchange Cap (19.99% of outstanding shares without stockholder approval).
Terms of the New Note
The New Note will have a
maturity date of 12 months from its issuance date (as may be extended at the option of the Investor). Interest will accrue on the outstanding
principal balance at an annual rate of 12%, which increases to 18% upon the occurrence of an event of default (for so long as such event
remains uncured). Interest is calculated based on a 365-day year and the actual number of days elapsed.
Beginning on the three-month
anniversary of the issuance date and continuing monthly, the Company must repay $200,000 of principal (or the outstanding principal if
less), plus a 7% payment premium and accrued interest (the “Installment Amount”). The Company may pay the Installment Amount
in cash or by submitting Advance Notices under the SEPA (with proceeds offsetting the Installment Amount). Any Advance Notice while the
New Note is outstanding is treated as repayment first.
The Company may, at its
option, redeem early a portion or all amounts outstanding under the New Note by providing written notice to the Investor, provided the
VWAP of the Common Stock was less than the conversion price on the notice date (unless otherwise agreed). The redemption amount includes
the principal being redeemed, a 5% redemption premium, and accrued interest. The Investor has 10 trading days to elect to convert any
portion of the New Note before redemption.
The New Note is convertible
at any time into shares of Common Stock at $12.00 per share, subject to adjustments for stock splits, combinations, reclassifications,
and dilutive issuances below the conversion price (with certain exclusions). Conversions are subject to a 4.99% beneficial ownership limitation.
Pursuant to the Letter Agreement, the Company granted
the Investor a right of first refusal for 12 months following September 11, 2025, with respect to any financing transaction involving
the issuance or sale of securities (including debt, equity, equity-linked securities, notes, or debentures, but excluding ATM offerings
at prevailing market prices). The Company must provide written notice of any such proposed transaction, and the Investor has 10 business
days to elect to participate. If the Investor declines, the Company may proceed with a third party on terms no more beneficial than those
offered to the Investor, within 60 days.
The New Note includes customary
events of default, representations, warranties, covenants, and indemnification provisions. Upon an event of default, the Investor may
accelerate the note or convert at the conversion price. The Company may not engage in variable rate transactions while the New Note is
outstanding, subject to exceptions.
Consulting Agreement
On September 26, 2025, the Company
finalized and entered into a Consulting Agreement (the “Agreement”) with Crypto Treasury Management Group, LLC (“CTMG”),
pursuant to which CTMG will provide advisory and strategic services to assist the Company in establishing a digital asset treasury reserve.
The services include, among other things, developing a crypto treasury strategy, recommending custodians, designing staking protocols
(if applicable), assisting with capital formation in collaboration with a licensed securities underwriter, and supporting regulatory and
tax compliance efforts.
The Agreement has an initial
term of two years, subject to earlier termination under certain conditions, including for convenience with 60 days’ notice or for
material breach. In consideration for the services, the Company has agreed to pay CTMG: (i) a retainer fee of $50,000 upon signing, which
was pre-paid as an advance on September 24, 2025, with an additional $50,000 upon execution of binding definitive agreements related to
the crypto treasury transaction; (ii) a success fee of 17 Bitcoin (or cash equivalent) upon successful deployment of at least $20 million
into crypto assets for the Company’s treasury; and (iii) 250,000 shares of the Company’s common stock upon closing of the
crypto treasury transaction, subject to SEC Rule 144 restrictions and inclusion in future registration statements where applicable. The
Company will also reimburse CTMG for pre-approved reasonable expenses.
The Agreement contemplates a
potential capital formation structure of up to $300 million, with allocations into crypto assets such as Bitcoin and Solana, subject to
the Company’s approval and market conditions; however, there can be no assurance that the transaction will close or that it will
be consummated on the anticipated terms or at all. In the event this strategy is successfully implemented, which is not guaranteed and
depends on various factors including management’s ability to execute effectively, the Company has committed to staking a minimum
of 70% of its crypto treasury assets for at least two years, although such implementation may face challenges or fail to achieve expected
outcomes due to market volatility, regulatory changes, or other risks. CTMG will not act as a broker-dealer or engage in activities requiring
such registration. The Company, in an effort to replace its current financing structure, intends to structure the transaction and use
the non-staked portion as funding for its defense business and potentially leverage the stakeable portion for M&A activity in the
defense arena, though these intentions are forward-looking and subject to uncertainties that could prevent or alter their realization.
The Agreement includes standard
provisions regarding confidentiality, non-circumvention, independent contractor status, compliance with laws (including securities, AML/KYC,
and tax regulations), warranties, indemnification, limitation of liability, and governing law (Delaware).
The proposed adoption of a
crypto reserve strategy, including the establishment of a digital asset treasury as contemplated in the Agreement will only be implemented
upon obtaining regulatory approval, if any, from relevant authorities, including compliance with Nasdaq listing requirements. Additionally,
the implementation of the crypto reserve strategy may require shareholder approval to the extent such approval is deemed necessary by
the Company’s board of directors or required by regulatory bodies. The Company will ensure all necessary approvals are obtained
prior to the execution of the crypto reserve strategy and will provide further updates as required by law.
Item 2. Management’s
Discussion and Analysis of Financial Condition and Results of Operations.
References to “we”,
“us”, “our” or the “Company” are to VisionWave Holdings, Inc., except where the context requires otherwise.
The following discussion should be read in conjunction with our unaudited condensed consolidated financial statements and related notes
thereto included elsewhere in this report.
Cautionary Note Regarding
Forward-Looking Statements
This Quarterly Report
on Form 10-Q includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section
21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). We have based these forward-looking statements
on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks,
uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially
different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements.
In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “could,”
“would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,”
“continue,” or the negative of such terms or other similar expressions. Factors that might cause or contribute to such a discrepancy
include, but are not limited to, those described in our other Securities and Exchange Commission (“SEC”) filings.
Overview
We were incorporated in Delaware
on September 3, 2024, and the Company’s registered office is at 108 W. 13th Street, Suite 100, City of Wilmington, Delaware. The
Company was formed as a wholly-owned subsidiary of Bannix Acquisition Corp. (“Bannix”).
Our subsidiaries include
BNIX Merger Sub, Inc. and BNIX VW Merger Sub, Inc.
BNIX Merger Sub, Inc. (“Parent
Merger Sub”) was incorporated in Delaware on September 3, 2024, and the Company’s registered office is at 108 W. 13th Street,
Suite 100, City of Wilmington, Delaware. The Company was formed as a wholly- owned subsidiary of the Company.
BNIX VW Merger Sub, Inc.
(“Company Merger Sub”) was incorporated in Nevada on September 4, 2024, and the Company’s registered office is at 701
S. Carson Street, Suite 200, Carson City, Nevada 89701. The Company was formed as a wholly-owned subsidiary of the Company.
Recent Developments
Proposed Business Combination
On September 6, 2024, Bannix entered into
a Merger Agreement and Plan of Reorganization (the “Merger Agreement”), by and among Bannix, the Company, BNIX Merger Sub,
Inc., a Delaware corporation and a direct, wholly owned subsidiary of the Company (“Parent Merger Sub”), BNIX VW Merger Sub,
Inc., a Nevada corporation and direct, wholly owned subsidiary of the Company (“Company Merger Sub”), and VisionWave Technologies,
Inc., a Nevada corporation (“Target”). The Merger Agreement and the transactions contemplated thereby were approved by the
boards of directors of each of Bannix, the Company, Parent Merger Sub, Company Merger Sub, and Target.
The Business Combination is expected to
close before July 31, 2025, subject to customary closing conditions, including the satisfaction of the minimum available cash condition,
the receipt of certain governmental approvals and the required approval by the stockholders of Bannix and Target.
Board of Directors
On September 9, 2025, the
Board of Directors (the “Board”) of the Company approved Independent Director Agreements (each, an “Agreement”)
with Eric Shuss, Chuck Hansen, and Haggai Ravid, pursuant to which each will serve as an independent director of the Company.
Under the terms of each
Agreement, the independent director will receive:
|
● |
An
annual cash retainer of $36,000, payable quarterly, and $10,000 per annum for serving as the audit committee chair, $5,000 for compensation
committee chair and the governance committee chair; |
|
● |
Reimbursement
for reasonable expenses incurred in connection with Board service; and |
|
● |
An
annual equity grant under the Company’s 2024 Omnibus Equity Incentive Plan (the “Plan”) with a grant date fair
value of $60,000, consisting of restricted stock vesting in full after one year of service. |
As a result of the above,
the Company will issue 5,245 shares of common stock to Messrs Shuss, Hansen and Ravid for their service in 2025.
Further, as compensation
for his service as a director prior to the Business Combination with Bannix Acquisition Corp. (“Bannix”), the Company entered
into Compensation Agreements (each, a “Compensation Agreement”) with Mr. Shuss and two other former directors who served as
an independent director on the Board of Directors of Bannix from October 2022 until July 2025. Pursuant to the Compensation Agreement,
effective as of September 9, 2025, Mr. Shuss will receive a one-time lump sum compensation of $150,000, payable in cash, fully vested
shares of the Company’s common stock issued under the Company’s Plan, or a combination thereof, at Mr. Shuss’ election.
If shares are elected, the number of shares will be determined by dividing the elected portion by the closing price of the Company’s
common stock on the NASDAQ Stock Market immediately prior to the effective date of the Compensation Agreement. Mr. Shuss has elected to
receive 6,556 shares of common stock using a closing price of $11.44 as of September 8, 2025. The shares will be fully vested upon issuance
but subject to resale restrictions under Rule 144 of the Securities Act of 1933, as amended. Payment or issuance will occur within 10
business days after the election (or default to cash if no election is made within 10 business days).
Financing
On September 11, 2025, the
Company entered into a letter agreement (the “Letter Agreement”) with YA II PN, Ltd., a Cayman Islands exempt limited partnership
(the “Investor”), pursuant to the Standby Equity Purchase Agreement, dated as of July 25, 2025 (as may be amended, amended
and restated, extended, supplemented or otherwise modified in writing from time to time, the “SEPA”), between the Company
and the Investor.
Pursuant to the Letter Agreement,
the Investor advanced the second tranche of the Pre-Paid Advance in a principal amount of $2,000,000 (the “Second Pre-Paid Advance”)
on September 11, 2025, in connection with the issuance by the Company of a convertible promissory note in the principal amount of $2,000,000
(the “Second Note”). The Investor waived the condition precedent set forth in the SEPA relating to the effectiveness of a
registration statement for the Second Pre-Paid Advance. The purchase price for the Second Note is $1,880,000 (94% of the principal amount,
reflecting a 6% discount).
In addition, pursuant to
the Letter Agreement, the Investor agreed to fund an additional $2,000,000 in principal amount (the “Additional Advance”)
under the terms of a new convertible promissory note in the principal amount of $2,000,000 (the “New Note” and, together with
the Second Note, the “Additional Notes”) upon the effectiveness of the registration statement filed by the Company on August
29, 2025, in connection with the SEPA (the “Registration Statement”). The purchase price for the New Note will be $1,880,000
(94% of the principal amount, reflecting a 6% discount). The Company acknowledged in the Letter Agreement that it is not required to modify,
amend, or supplement the existing Registration Statement to include any shares underlying the New Note, and, other than as may be set
forth in the New Note, the Company is not obligated to file a new registration statement relating to such shares.
Terms of the Second Note
The Second Note has a maturity
date of September 11, 2026 (as may be extended at the option of the Investor). Interest accrues on the outstanding principal balance at
an annual rate of 6%, which increases to 18% upon the occurrence of an event of default (for so long as such event remains uncured). Interest
is calculated based on a 365-day year and the actual number of days elapsed.
If an Amortization Event
occurs (defined as a Floor Price Event, Exchange Cap Event, or Registration Event, as set forth in the Second Note), the Company must
make monthly cash payments beginning on the 10th trading day after the Amortization Event Date and continuing on the same day of each
successive calendar month until the entire outstanding principal amount is repaid. Each monthly payment equals the sum of (i) $750,000
of principal (or the outstanding principal if less), (ii) a 7% payment premium on such principal amount, and (iii) accrued and unpaid
interest. The obligation to make such payments ceases if the Amortization Event is cured.
The Company may, at its
option, redeem early a portion or all amounts outstanding under the Second Note by providing written notice to the Investor, provided
the VWAP of the common stock was less than the fixed conversion price on the notice date (unless otherwise agreed). The redemption amount
includes the principal being redeemed, a 5% redemption premium, and accrued interest. The Investor has 10 trading days to elect to convert
any portion of the Second Note before redemption.
The Second Note is convertible
at any time into shares of the Company’s common stock, par value $0.01 per share (the “Common Stock”), at the lower
of (i) $10.00 per share (the “Fixed Price”) or (ii) 93% of the lowest daily VWAP during the 5 consecutive trading days immediately
preceding the conversion date (the “Variable Price”), but not lower than the floor price of $1.00 per share (adjustable downwards
to 20% of the average VWAP for the five trading days prior to the earlier of the Registration Statement effectiveness or the six-month
anniversary of the SEPA date, or further reduced by the Company). The Fixed Price resets downwards on the 30-day anniversary of a merger
transaction to the average VWAP for the five trading days prior. Conversions are subject to a 4.99% beneficial ownership limitation and
the Exchange Cap (19.99% of outstanding shares without stockholder approval).
Terms of the New Note
The New Note will have a
maturity date of 12 months from its issuance date (as may be extended at the option of the Investor). Interest will accrue on the outstanding
principal balance at an annual rate of 12%, which increases to 18% upon the occurrence of an event of default (for so long as such event
remains uncured). Interest is calculated based on a 365-day year and the actual number of days elapsed.
Beginning on the three-month
anniversary of the issuance date and continuing monthly, the Company must repay $200,000 of principal (or the outstanding principal if
less), plus a 7% payment premium and accrued interest (the “Installment Amount”). The Company may pay the Installment Amount
in cash or by submitting Advance Notices under the SEPA (with proceeds offsetting the Installment Amount). Any Advance Notice while the
New Note is outstanding is treated as repayment first.
The Company may, at its
option, redeem early a portion or all amounts outstanding under the New Note by providing written notice to the Investor, provided the
VWAP of the Common Stock was less than the conversion price on the notice date (unless otherwise agreed). The redemption amount includes
the principal being redeemed, a 5% redemption premium, and accrued interest. The Investor has 10 trading days to elect to convert any
portion of the New Note before redemption.
The New Note is convertible
at any time into shares of Common Stock at $12.00 per share, subject to adjustments for stock splits, combinations, reclassifications,
and dilutive issuances below the conversion price (with certain exclusions). Conversions are subject to a 4.99% beneficial ownership limitation.
Pursuant to the Letter Agreement, the Company granted
the Investor a right of first refusal for 12 months following September 11, 2025, with respect to any financing transaction involving
the issuance or sale of securities (including debt, equity, equity-linked securities, notes, or debentures, but excluding ATM offerings
at prevailing market prices). The Company must provide written notice of any such proposed transaction, and the Investor has 10 business
days to elect to participate. If the Investor declines, the Company may proceed with a third party on terms no more beneficial than those
offered to the Investor, within 60 days.
The New Note includes customary
events of default, representations, warranties, covenants, and indemnification provisions. Upon an event of default, the Investor may
accelerate the note or convert at the conversion price. The Company may not engage in variable rate transactions while the New Note is
outstanding, subject to exceptions.
Close of Business Combination
On July 14, 2025, the Company
closed on its proposed Business Combination and liquidated its Trust Account. In association with the liquidation of the Trust Account,
stockholders redeeming their shares of common stock at the May 2025 Special Meeting were paid for their redeeming shares.
Consulting Agreement
On September 26, 2025, the Company
finalized and entered into a Consulting Agreement (the “Agreement”) with Crypto Treasury Management Group, LLC (“CTMG”),
pursuant to which CTMG will provide advisory and strategic services to assist the Company in establishing a digital asset treasury reserve.
The services include, among other things, developing a crypto treasury strategy, recommending custodians, designing staking protocols
(if applicable), assisting with capital formation in collaboration with a licensed securities underwriter, and supporting regulatory and
tax compliance efforts.
The Agreement has an initial
term of two years, subject to earlier termination under certain conditions, including for convenience with 60 days’ notice or for
material breach. In consideration for the services, the Company has agreed to pay CTMG: (i) a retainer fee of $50,000 upon signing, which
was pre-paid as an advance on September 24, 2025, with an additional $50,000 upon execution of binding definitive agreements related to
the crypto treasury transaction; (ii) a success fee of 17 Bitcoin (or cash equivalent) upon successful deployment of at least $20 million
into crypto assets for the Company’s treasury; and (iii) 250,000 shares of the Company’s common stock upon closing of the
crypto treasury transaction, subject to SEC Rule 144 restrictions and inclusion in future registration statements where applicable. The
Company will also reimburse CTMG for pre-approved reasonable expenses.
The Agreement contemplates a
potential capital formation structure of up to $300 million, with allocations into crypto assets such as Bitcoin and Solana, subject to
the Company’s approval and market conditions; however, there can be no assurance that the transaction will close or that it will
be consummated on the anticipated terms or at all. In the event this strategy is successfully implemented, which is not guaranteed and
depends on various factors including management’s ability to execute effectively, the Company has committed to staking a minimum
of 70% of its crypto treasury assets for at least two years, although such implementation may face challenges or fail to achieve expected
outcomes due to market volatility, regulatory changes, or other risks. CTMG will not act as a broker-dealer or engage in activities requiring
such registration. The Company, in an effort to replace its current financing structure, intends to structure the transaction and use
the non-staked portion as funding for its defense business and potentially leverage the stakeable portion for M&A activity in the
defense arena, though these intentions are forward-looking and subject to uncertainties that could prevent or alter their realization.
The Agreement includes standard
provisions regarding confidentiality, non-circumvention, independent contractor status, compliance with laws (including securities, AML/KYC,
and tax regulations), warranties, indemnification, limitation of liability, and governing law (Delaware).
The proposed adoption of a crypto
reserve strategy, including the establishment of a digital asset treasury as contemplated in the Agreement will only be implemented upon
obtaining regulatory approval, if any, from relevant authorities, including compliance with Nasdaq listing requirements. Additionally,
the implementation of the crypto reserve strategy may require shareholder approval to the extent such approval is deemed necessary by
the Company’s board of directors or required by regulatory bodies. The Company will ensure all necessary approvals are obtained
prior to the execution of the crypto reserve strategy and will provide further updates as required by law.
Results of Operations
The company was formed for the purpose of effectuating
a business combination. We will not generate any operating revenues until the closing and completion of our proposed business combination,
at the earliest.
For the three months ended March 31, 2025,
we had a net loss of $60,253, which consisted of operating expenses.
For the six months ended March 31, 2025,
we had a net loss of $63,253, which consisted of operating expenses.
Liquidity, Capital Resources,
and Going Concern
The Company was formed for the purpose
of consummating a business combination and is not anticipated to exist upon consummation of the Merger Agreement.
The parent company, Bannix, is within 12
months of its mandatory liquidation date as of June 30, 2025. In connection with the Company’s assessment of going concern considerations,
the Company had a temporarily extended deadline date beyond the June 14, 2025 Deadline Date to consummate a Business Combination. The
Company closed on its proposed Business Combination on July 14, 2025 alleviating the mandatory liquidation requirement.
Based on the foregoing, management believes
that the funds the Company has available is sufficient to meet its operating needs through the consummation of a Business Combination
through the temporarily extended Deadline Date. Over this time period, the Company will be utilizing the funds available to it to pay
existing accounts payable and consummating the proposed Business Combination.
In connection with preparing
the financial statements for the Three and Six months ended March 31, 2025, management evaluated whether there were conditions and events,
considered in the aggregate, that raised substantial doubt about the Company’s ability to continue as a going concern within one
year from the date that the consolidated financial statements are issued.
As of March 31, 2025, the Company had no
cash, a working capital deficit of $66,309 and no sources of funding other than funds that may be obtained from related parties.
Ordinarily, conditions or events that raise
substantial doubt about an entity’s ability to continue as a going concern relate to the entity’s ability to meet its obligations
as they become due.
The Company evaluated its ability to meet
its obligations as they become due within one year from the date that the financial statements are issued by considering the following:
On April 8, 2025, with an effective date
of March 31, 2025, Bannix, together with the Company, entered into a Funding Support Agreement with Stanley Hills, LLC (“Stanley
Hills”), the principal shareholder of the VisionWave Technologies, Inc. Pursuant to the agreement, Stanley Hills irrevocably and
unconditionally committed to provide financial support to Bannix, sufficient to fund working capital needs for a period not less than
twelve (12) months from the date of release/issuance of the financial statement.
The funding may be provided by Stanley
Hills in the form of direct payments to third parties, advances or intercompany loans, or capital contributions, as mutually determined
by the parties. Unless otherwise agreed in writing, any such advances will be non-interest bearing and repayable only at such time as
determined by the applicable entity’s Board of Directors, and only to the extent such repayment would not impair the Company’s
liquidity or ability to continue as a going concern. The agreement may not be terminated by Stanley Hills prior to the twelve-month period
from the date of release of the financial statement.
Management has determined that the agreement
with Stanley Hills and closing of the business combination elevated the risk about the Company’s ability to continue as a going
concern for a reasonable period of time, which is considered to be one year from the issuance of the financial statements.
The merger closing triggered substantial,
actionable, and committed below funding access:
• Investor A is actively pushing
to draw $2 million immediately and has committed to a $50 million equity line.
• Investor B has offered the Company
$2 million in $300K tranches, and is likewise eager for us to proceed post-closing.
• Investor C is to finalize their
$18 million ELOC and a $5 million pre-paid advance.
Cash Flow Analysis
For the six months ended March 31, 2025, cash used
in operating activities was $44,500. We had a net loss of $63,253. We benefited by changes in operating assets and liabilities of $18,753.
Cash provided by financing activities was $44,500 which was proceeds from related parties.
Critical Accounting Estimates
The preparation of these
financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts
of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported
amounts of expenses during the reporting period. Actual results could differ from those estimates. We have determined there are no critical
accounting estimates.
Recently Issued Accounting
Pronouncements
In November 2023, the FASB
issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (ASU 2023-07), which improves reportable
segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses among other disclosure requirements.
ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December
15, 2024. Early adoption is permitted. The Company adopted ASU 2023-07 on October 1, 2024. The amendments will be applied retrospectively
to all prior periods presented in the financial statements. The adoption of ASU 2023-07 has not had a material impact on the Company’s
unaudited condensed consolidated financial statements and disclosures.
The Company has reviewed
recently issued accounting pronouncements and plans to adopt those that are applicable to it.
The Company does not expect
the adoption of any recently issued pronouncements to have a material impact on its results of operations or financial position.
Off-Balance Sheet
Arrangements; Commitments and Contractual Obligations
None.
Item 3. Quantitative
and Qualitative Disclosures About Market Risk
As a smaller reporting company,
we are not required to make disclosures under this Item.
Item 4. Controls
and Procedures
Evaluation of Disclosure
Controls and Procedures
Disclosure controls are procedures
that are designed with the objective of ensuring that information required to be disclosed in our reports filed under the Exchange Act,
such as this Report, is recorded, processed, summarized, and reported within the time period specified in the SEC’s rules and
forms. Disclosure controls are also designed with the objective of ensuring that such information is accumulated and communicated to our
management, including the chief executive officer, as appropriate to allow timely decisions regarding required disclosure. Our management
evaluated, with the participation of our current chief executive officer (our “Certifying Officer”), the effectiveness of
our disclosure controls and procedures as of March 31, 2025, pursuant to Rule 13a-15(b) under the Exchange Act. Based upon that
evaluation, our Certifying Officers concluded that, as of March 31, 2025, our disclosure controls and procedures were not effective due
to material weakness in our internal controls over financial reporting of complex financial instruments, fair value measurements, prepaid
expense, income and franchise taxes and legal and professional fees.
Disclosure controls and procedures
are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized,
and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated
to our management team, including our chief executive officer or persons performing similar functions, as appropriate to allow timely
decisions regarding required disclosure.
We do not expect that our
disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how
well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures
are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the
benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no
evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and
instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood
of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future
conditions.
Material Weakness
A
material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a
reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on
a timely basis. On April 12, 2021, the staff of the SEC (the “SEC Staff”)
issued a public statement entitled “Staff Statement on
Accounting and Reporting Considerations for Warrants issued by Special Purpose Acquisition Companies (“SPACs”)”
(the “SEC Staff Statement”).
In the SEC Staff Statement, the SEC Staff expressed its view that certain terms and conditions common to SPAC warrants may require the
warrants to be classified as liabilities on the SPAC’s
balance sheet as opposed to equity. In light of the SEC Staff Statement, the Company’s
management reevaluated the terms of the Public Warrants and Private Placement Warrants (together, the “warrants”),
and determined that the Public Warrants should be classified as a component of equity. Our Private Placement Warrants were correctly reported
as a liability measured at fair value upon issuance, with subsequent changes in fair value reported in earnings each reporting period.
Additionally, management
evaluated the impacts of the transfer of shares to Anchor Investors. The transfer of shares to the Anchor Investors were fair valued as
of the grant date and that fair value was allocated to the offering costs of the Company.
Associated with the reclassification
of the Public Warrants to equity and the valuation of the Anchor Investor shares, the allocation of offering costs was re-allocated.
Additionally, we had a misstatement
in our prepaid expense, income and franchise taxes and legal fees.
As a result of these reevaluations,
management identified a material weakness in our internal control over financial reporting related to the accounting for complex financial
instruments and fair value measurements and the failure to properly design the financial closing and reporting process to record, review
and monitor compliance with generally accepted accounting principles for transactions on a timely basis.
Changes in Internal
Control over Financial Reporting
There were no changes in
our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange
Act) during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal
control over financial reporting.
PART II—OTHER INFORMATION
Item 1. Legal Proceedings
In September 2025, a shareholder filed a lawsuit against the Company seeking
from court a declaration that it is not an affiliate of the Company. The Company is contesting the shareholder’s position. At each
reporting date, the Company evaluates whether or not a potential loss amount or a potential range of loss is probable and reasonably estimable
under the provisions of the authoritative guidance that addresses accounting for contingencies. At this phase the Company cannot estimate
the results of said litigation. The Company expenses as incurred the costs related to such legal proceedings.
Item 1A. Risk Factors
We have identified
a material weakness in our internal control over financial reporting as of March 31, 2025. If we are unable to develop and maintain an
effective system of internal control over financial reporting, we may not be able to accurately report our financial results in a timely
manner, which may adversely affect investor confidence in us and materially and adversely affect our business and operating results.
As described elsewhere in
this Quarterly Report on Form 10-Q, we have identified a material weakness in our internal control over financial reporting related to
the Company’s accounting and reporting of complex financial instruments. As a result of this material weakness, our management has
concluded that our disclosure controls and procedures were not effective as of March 31, 2025. See Part I. Item 4. Controls and Procedures
included in this Quarterly Report on Form 10-Q. We have taken measures to remediate the material weaknesses described herein. However,
if we are unable to remediate our material weaknesses in a timely manner or we identify additional material weaknesses, we may be unable
to provide required financial information in a timely and reliable manner and we may incorrectly report financial information. Likewise,
if our financial statements are not filed on a timely basis, we could be subject to sanctions or investigations by the stock exchange
on which our common stock are listed, the SEC or other regulatory authorities. The existence of material weaknesses in internal control
over financial reporting could adversely affect our reputation or investor perceptions of us, which could have a negative effect on the
trading price of our shares. We can give no assurance that the measures we have taken and plan to take in the future will remediate the
material weakness identified or that any additional material weaknesses or restatements of financial results will not arise in the future
due to a failure to implement and maintain adequate internal control over financial reporting or circumvention of these controls. Even
if we are successful in strengthening our controls and procedures, in the future those controls and procedures may not be adequate to
prevent or identify irregularities to facilitate the fair presentation of our financial statements.
A material weakness is a
deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility
that a material misstatement of our annual or interim financial statements will not be prevented or detected and corrected on a timely
basis.
Effective internal controls
are necessary for us to provide reliable financial reports and prevent fraud. We continue to evaluate steps to remediate the material
weakness. These remediation measures may be time consuming and costly and there is no assurance that these initiatives will ultimately
have the intended effects.
If we identify any new material
weaknesses in the future, any such newly identified material weakness could limit our ability to prevent or detect a misstatement of our
accounts or disclosures that could result in a material misstatement of our annual or interim financial statements. In such case, we may
be unable to maintain compliance with securities law requirements regarding timely filing of periodic reports in addition to applicable
stock exchange listing requirements, investors may lose confidence in our financial reporting and our stock price may decline as a result.
We cannot assure you that any measures we may take in the future, will be sufficient to avoid potential future material weaknesses.
Item 2. Unregistered
Sales of Equity Securities and Use of Proceeds.
None
Item 3. Defaults
Upon Senior Securities
None.
Item 4. Mine Safety
Disclosures
None.
Item 5. Other Information
During the quarter ended March 31, 2025, no director
or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,”
as each term is defined in Item 408(a) of Regulation S-K.
Item 6. Exhibits
|
|
|
Incorporated
by Reference |
Exhibit |
|
Description |
|
Schedule/
Form |
|
File
Number |
|
Exhibits |
|
Filing
Date |
2.1 |
|
Merger Agreement and Plan of Reorganization by and among Bannix Acquisition Corp., VisionWave Holdings, Inc., BNIX Merger Sub, Inc. and BNIX VW Merger Sub, Inc. dated September 6, 2024 (included as Annex A to the proxy statement/prospectus) |
|
Form
S-4 |
|
333-284472 |
|
2.1 |
|
April
18, 2025 |
3.1 |
|
Amended and Restated Certificate of Incorporation of VisionWave Holdings Inc. |
|
Form
8-K |
|
001-42741 |
|
3.1 |
|
July
14, 2025 |
3.2 |
|
Bylaws of VisionWave Holdings Inc. |
|
Form
8-K |
|
001-42741 |
|
3.2 |
|
July
14, 2025 |
10.1 |
|
VisionWave Holdings Inc. 2024 Incentive Equity Plan |
|
Form
8-K |
|
001-42741 |
|
10.1 |
|
July
14, 2025 |
10.2 |
|
Standby Equity Purchase Agreement, dated July 25, 2025, between VisionWave Holdings, Inc. and YA II PN, Ltd. |
|
Form
8-K |
|
001-42741 |
|
10.1 |
|
July
28, 2025 |
10.3 |
|
Form of Convertible Promissory Notes issued to YA II PN, Ltd. |
|
Form
8-K |
|
001-42741 |
|
10.2 |
|
July
28, 2025 |
10.4 |
|
Registration Rights Agreement, dated July 25, 2025, between VisionWave Holdings, Inc. and YA II PN, Ltd. |
|
Form
8-K |
|
001-42741 |
|
10.3 |
|
July
28, 2025 |
10.5 |
|
Global Guaranty Agreement by VisionWave Technologies, Inc. in favor of YA II PN, LTD. dated July 25, 2025 |
|
Form
8-K |
|
001-42741 |
|
10.4 |
|
July
28, 2025 |
10.6 |
|
2025 Omnibus Equity Incentive Plan |
|
Form
8-K |
|
001-42741 |
|
10.1 |
|
August
6, 2025 |
10.7 |
|
Employment Agreement, dated August 6, 2025, by and between the Company and Douglas Davis |
|
Form
8-K |
|
001-42741 |
|
10.2 |
|
August
6, 2025 |
10.8 |
|
Employment Agreement, dated August 6, 2025, by and between the Company and Noam Kenig |
|
Form
8-K |
|
001-42741 |
|
10.3 |
|
August
6, 2025 |
10.9 |
|
Employment Agreement, dated August 6, 2025, by and between the Company and Danny Rittman |
|
Form
8-K |
|
001-42741 |
|
10.4 |
|
August
6, 2025 |
10.10 |
|
Form of Nonstatutory Stock Option Agreement, dated August 6, 2025 |
|
Form
8-K |
|
001-42741 |
|
10.5 |
|
August
6, 2025 |
10.11 |
|
Form of Proprietary & Confidential Information, Inventions Assignment, Non-Solicitation and Non-Competition Agreement |
|
Form
8-K |
|
001-42741 |
|
10.6 |
|
August
6, 2025 |
10.12 |
|
Form of Mutual Agreement to Arbitrate |
|
Form
8-K |
|
001-42741 |
|
10.7 |
|
August
6, 2025 |
10.13* |
|
Form of Securities Purchase Agreement dated July 15, 2025 |
|
|
|
|
|
|
|
|
10.14* |
|
Form of Promissory Note dated July 15, 2025 |
|
|
|
|
|
|
|
|
14.1 |
|
Code of Ethics of VisionWave Holdings Inc. |
|
Form
8-K |
|
001-42741 |
|
14.1 |
|
July
22, 2025 |
31.1* |
|
Certification
of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant
to Section 302 of the Sarbanes-Oxley Act of 2002. |
|
|
|
|
|
|
|
|
31.2* |
|
Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
|
|
|
|
|
|
|
|
32.1*+ |
|
Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
|
|
|
|
|
|
|
|
32.2*+ |
|
Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
|
|
|
|
|
|
|
|
97 |
|
Compensation Recovery Policy of VisionWave Holdings Inc., effective May 29, 2025 |
|
Form
8-K |
|
001-42741 |
|
99.3 |
|
July
22, 2025 |
99.1 |
|
Policy on Granting Equity Awards of VisionWave Holdings Inc., adopted July 16, 2025 |
|
Form
8-K |
|
001-42741 |
|
99.1 |
|
July
22, 2025 |
99.2 |
|
Insider Trading Policy of VisionWave Holdings Inc., adopted July 16, 2025 |
|
Form
8-K |
|
001-42741 |
|
99.2 |
|
July
22, 2025 |
Exhibit Number |
|
Description |
|
|
|
101.INS* |
|
XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document |
|
|
|
101.SCH* |
|
XBRL Taxonomy Extension Schema Document |
|
|
|
101.CAL* |
|
XBRL Taxonomy Extension Calculation Linkbase Document |
|
|
|
101.DEF* |
|
XBRL Taxonomy Extension Definition Linkbase Document |
|
|
|
101.LAB* |
|
XBRL Taxonomy Extension Label Linkbase Document |
|
|
|
101.PRE* |
|
XBRL Taxonomy Extension Presentation Linkbase Document |
|
|
|
104* |
|
Cover Page Interactive Data File - The cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document |
* |
Filed herewith. |
|
|
+ |
These certifications are furnished to the SEC pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing. |
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
VISIONWAVE
HOLDINGS, INC. |
|
|
|
Date: October 3, 2025 |
By: |
/s/
Douglas Davis |
|
Name: |
Douglas
Davis |
|
Title: |
Executive Chairman |
|
|
(Principal Executive Officer) |
|
|
|
|
VISIONWAVE
HOLDINGS, INC. |
|
|
|
Date: October 3, 2025 |
By: |
/s/
Noam Kenig |
|
Name: |
Noam
Kenig |
|
Title: |
Chief Executive Officer (Principal Executive Officer) |
|
VISIONWAVE
HOLDINGS, INC. |
|
|
|
Date: October 3, 2025 |
By: |
/s/
Erik Klinger |
|
Name: |
Erik
Klinger |
|
Title: |
Chief Financial Officer |
|
|
(Principal Financial and Accounting
Officer) |
26